This document provides guidance on the data from pharmaceutical development studies required for marketing authorisation of veterinary medicinal products. It applies to pharmaceuticals produced by chemical synthesis.

Keywords: Development pharmaceutics, formulation, quality, product, dosage form, veterinary medicinal product (VMP)

Current effective version

Document history

Share this page